Publication | Closed Access

Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease

NanoparticlesNanomedicineNeurodegenerative DiseasesAlzheimer's DiseaseNanotherapeuticsEngineeringMedicinePeptide EngineeringSialic AcidPeptide ScienceNeurologyBiomedical EngineeringSelenium NanoparticlesAlzheimer ’Protein Nanoparticles